For example, a study identified a subpopulation of circulating CD8+ T cells, similarly enriched for expression of CD38 and HLA-DR, whose abundance within the primary tumor and within PBMCs changed after a 3-week course of checkpoint blockade therapy50. This evidence concerns the gene CD38 and neoplasm.